{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T05:24:03Z","timestamp":1787117043456,"version":"build-2736575974"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,18]]},"DOI":"10.7759\/cureus.114767","type":"journal-article","created":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T04:26:46Z","timestamp":1787113606000},"source":"Crossref","is-referenced-by-count":0,"title":["Recurrent Transient Paresthesias After Revascularization for Moyamoya Disease: Hemodynamic Diagnostic Challenges in a Patient With Post-radioiodine Hypothyroidism"],"prefix":"10.7759","author":[{"given":"Tara","family":"Sanjabi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ava","family":"Sanjabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lilia","family":"Olsick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kian","family":"Memari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio A","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas A","family":"Trum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Lajara-Nanson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Moyamoya Disease","author":"Karsonovich T","year":"2025","unstructured":"Karsonovich T, Lui F. Moyamoya Disease. StatPearls, Treasure Island; 2025."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.2176\/jns-nmc.2022-0072","article-title":"Diagnostic criteria for moyamoya disease \u2014 2021 revised version","volume":"62","author":"Kuroda S","year":"2022","unstructured":"Kuroda S, Fujimura M, Takahashi J, et al.. Diagnostic criteria for moyamoya disease \u2014 2021 revised version. Neurol Med Chir. 2022, 62:307-312. 10.2176\/jns-nmc.2022-0072","journal-title":"Neurol Med Chir"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1159\/000528055","article-title":"Ethnic-associated phenotype variations in moyamoya cerebrovascular outcomes","volume":"52","author":"Unda SR","year":"2023","unstructured":"Unda SR, Antoniazzi AM, Fluss R, Yassari N, Esenwa C, Haranhalli N, Altschul DJ. Ethnic-associated phenotype variations in moyamoya cerebrovascular outcomes. Cerebrovasc Dis. 2023, 52:519-525. 10.1159\/000528055","journal-title":"Cerebrovasc Dis"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000214013","article-title":"Demographic disparities in the incidence of moyamoya angiopathy in the United States","volume":"105","author":"Miller R","year":"2025","unstructured":"Miller R, Anikpezie N, Hoffman H, et al.. Demographic disparities in the incidence of moyamoya angiopathy in the United States. Neurology. 2025, 105:e214013. 10.1212\/WNL.0000000000214013","journal-title":"Neurology"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1161\/STR.0000000000000443","article-title":"Adult moyamoya disease and syndrome: current perspectives and future directions: a scientific statement from the American Heart Association\/American Stroke Association","volume":"54","author":"Gonzalez NR","year":"2023","unstructured":"Gonzalez NR, Amin-Hanjani S, Bang OY, et al.. Adult moyamoya disease and syndrome: current perspectives and future directions: a scientific statement from the American Heart Association\/American Stroke Association. Stroke. 2023, 54:e465-e479. 10.1161\/STR.0000000000000443","journal-title":"Stroke"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.wneu.2019.04.062","article-title":"Meta-analysis of prognosis of different treatments for symptomatic moyamoya disease","volume":"127","author":"Li Q","year":"2019","unstructured":"Li Q, Gao Y, Xin W, et al.. Meta-analysis of prognosis of different treatments for symptomatic moyamoya disease. World Neurosurg. 2019, 127:354-361. 10.1016\/j.wneu.2019.04.062","journal-title":"World Neurosurg"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.5853\/jos.2024.04273","article-title":"Medical management of adult moyamoya disease: a review and relevant cases with ischemic events","volume":"27","author":"Bang OY","year":"2025","unstructured":"Bang OY, Fujimura M. Medical management of adult moyamoya disease: a review and relevant cases with ischemic events. J Stroke. 2025, 27:1-18. 10.5853\/jos.2024.04273","journal-title":"J Stroke"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jocn.2024.110956","article-title":"Benefits and risks of antiplatelet therapy after bypass surgery for moyamoya disease: a meta-analysis","volume":"132","author":"Si J","year":"2025","unstructured":"Si J, Kang X, Li Z, Hao J, Zhang L. Benefits and risks of antiplatelet therapy after bypass surgery for moyamoya disease: a meta-analysis. J Clin Neurosci. 2025, 132:110956. 10.1016\/j.jocn.2024.110956","journal-title":"J Clin Neurosci"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2023.1132339","article-title":"Benefits and risks of antiplatelet therapy for moyamoya disease: a systematic review and meta-analysis","volume":"14","author":"Liu T","year":"2023","unstructured":"Liu T, Qin M, Xiong X, Li T, Feng L, Lai X, Gao Y. Benefits and risks of antiplatelet therapy for moyamoya disease: a systematic review and meta-analysis. Front Neurol. 2023, 14:1132339. 10.3389\/fneur.2023.1132339","journal-title":"Front Neurol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2017.11.013","article-title":"Increased serum production of soluble CD163 and CXCL5 in patients with moyamoya disease: Involvement of intrinsic immune reaction in its pathogenesis","volume":"1679","author":"Fujimura M","year":"2018","unstructured":"Fujimura M, Fujimura T, Kakizaki A, et al.. Increased serum production of soluble CD163 and CXCL5 in patients with moyamoya disease: Involvement of intrinsic immune reaction in its pathogenesis. Brain Res. 2018, 1679:39-44. 10.1016\/j.brainres.2017.11.013","journal-title":"Brain Res"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1233567","article-title":"Research progress on moyamoya disease combined with thyroid diseases","volume":"14","author":"Zhang G","year":"2023","unstructured":"Zhang G, Liu E, Tan X, Liu C, Yang S. Research progress on moyamoya disease combined with thyroid diseases. Front Endocrinol. 2023, 14:1233567. 10.3389\/fendo.2023.1233567","journal-title":"Front Endocrinol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/480197-recurrent-transient-paresthesias-after-revascularization-for-moyamoya-disease-hemodynamic-diagnostic-challenges-in-a-patient-with-post-radioiodine-hypothyroidism","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T04:26:46Z","timestamp":1787113606000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/480197-recurrent-transient-paresthesias-after-revascularization-for-moyamoya-disease-hemodynamic-diagnostic-challenges-in-a-patient-with-post-radioiodine-hypothyroidism"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,18]]},"references-count":11,"URL":"https:\/\/doi.org\/10.7759\/cureus.114767","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8,18]]}}}